Delay in diagnosis and treatment of patients with cases of imported malaria in Poland : one center’s experience by Czepiel, Jacek et al.
ORIGINAL PAPERS
Family Medicine & Primary Care Review 2017; 19(2): 93–97
© Copyright by Wydawnictwo Continuo
doi: 10.5114/fmpcr.2017.65084
Delay in diagnosis and treatment of patients with cases  
of imported malaria in Poland – one center’s experience
Jacek czepiel1, A–F, Sarah Goldman2, B, E, F, AnAstAzjA szlAuer-stefAńskA2, B, E, F,  
alekSandra mielimonka2, B, E, F, GrAżynA BiesiAdA1, D–F, AnnA kAlinowskA-nowAk1, E, 
AleksAndrA wesełuchA-BirczyńskA3, E, William perucki4, E, alekSander Garlicki1, D, E
1 department of infectious and tropical diseases chair of Gastroenterology, hepatology and infectious diseases, 
jagiellonian university Medical college, cracow, Poland 
2 student’s scientific society, jagiellonian university, Medical college, cracow, Poland
3 department of chemical Physics, faculty of chemistry, jagiellonian university, cracow, Poland
4 department of Medicine, john dempsey hospital, university of connecticut, farmington, ct, usA
A – study design, B – data collection, C – statistical Analysis, D – data interpretation, E – Manuscript Preparation, F – literature 
search, G – funds collection
Background. increasingly, Polish citizens are traveling to malaria endemic regions; thus, physicians, especially primary 
care physicians, should be educated to recognize and treat malaria. diagnosis and treatment of malaria encounters many difficulties 
in Poland.
Objectives. the aim of the study was to analyze malaria chemoprophylaxis, the time from first symptoms to hospitalization and the 
process of diagnosis and treatment of patients with malaria.
Material and methods. the medical records of patients diagnosed with malaria, hospitalized between 2012 and 2016 in the depart-
ment of infectious diseases of the university hospital, cracow, Poland, were analyzed. 
Results. 37 subjects with a median age of 32 years (interquartile range iQr: 28–40), mostly returning from Africa (78%, n = 29), were 
studied. Proper chemoprophylaxis was used in 6 cases (16%). the median length of stay in malaria endemic countries was one month. 
Plasmodium falciparum was the most frequent species (74%). the mean time to treatment after symptom onset was 5 days (range: 
1–27 days).
Conclusions. the clinical presentation of malaria in the study group was usually typical. diagnostic delay resulted from not taking 
malaria into consideration during the initial differential diagnosis of fever. few travelers use chemoprophylaxis, hence the awareness 
of malaria in individuals who have traveled to endemic zones should be enhanced. in a patient presenting with fever, malaria should 
always be considered in a differential diagnosis if there is a history of travel to a malaria-endemic zone.
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Background
Malaria is one of the most important human parasitic dis-
eases and is the leading cause of deaths in tropical zones. it is 
caused by parasites of the Plasmodium genus, among which 5 
species are pathogenic. the majority of malaria cases are caused 
by P. falciparum and P. vivax, whereas P. ovale, P. malariae and 
zoonotic P. knowlesi are less frequent. P. falciparum causes the 
most severe form of malaria, along with the majority of deaths 
from malaria. the disease is most commonly transmitted by an 
infected female Anopheles mosquito [1]. there are 400 Anoph-
eles species in the world, but only 30 are malaria vectors [2].
According to the world health organization’s (who) world 
Malaria report 2015, transmission risk exists in 95 countries, 
mostly in Africa, Asia, south America and some Pacific islands. 
Almost 3.2 billion people inhabit these areas, and almost 1 bil-
lion people live in high transmission risk areas (> 1 case per 
1000 population). Malaria primarily affects low income coun-
tries, which complicates efforts to combat the infection. Global 
financing for malaria control reached 2.5 billion usd in 2014. to 
achieve a 75% reduction in malaria incidence and deaths, an-
nual financing should be increased to 7.7 billion usd by 2025. 
Although the number of malaria cases has fallen since 2000, the 
incidence rate is still high (214 million cases in 2015). 70% of 
deaths from malaria occurred in children under 5 years of age. 
80% of deaths in 2015 were in the African region, mostly in sub-
saharan Africa. P. vivax is estimated to have been responsible 
for 13.8 million cases of malaria globally in 2015 and accounted 
for approximately half the total number of cases of malaria out-
side Africa. P. falciparum is the most prevalent malaria parasite 
on the African continent. it is responsible for most malaria- 
-related deaths globally. the exact percentage of the remaining 
three species is difficult to determine; however, they cause ma-
laria much less frequently than P. vivax/P. falciparum [3].
Poland was a malaria-endemic country until the 1950s, with 
endemic transmission of P. vivax [4]. the highest rate of inci-
dence was noted in the 1920s, with rates of up to 197.1/100 000 
inhabitants [5]. Although Poland was declared as a malaria-free 
country in 1968, there is still a possibility of local transmission of 
the Plasmodium genus. there are 5 species of Anopheles mos-
quitos in Poland, all potentially able to infect themselves from 
the blood of a patient with parasitemia. in recent years, only 
imported cases of malaria have been diagnosed with a predom-
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inance of P. falciparum malaria [6, 7]. the rate of death from 
severe malaria in Poland in recent years has been around 1.4% 
and is 7–16 times higher than in other european countries [5]. 
since 1975, all of europe is malaria-free, although local trans-
mission of malaria in Greece was reported in 2010–2012. this 
suggests that sporadic Plasmodium transmission in the Medi-
terranean Basin is still possible [6].
Objectives
the aim of the study was to analyze malaria chemoprophy-
laxis, the time from first symptoms to hospitalization and the 
process of diagnosis and treatment among patients with ma-
laria.
Material and methods
we planned a retrospective case review study in which we 
included patients diagnosed with malaria between 2012–2016 
at the department of infectious diseases of university hospital 
in cracow. the diagnosis of malaria was made based on medi-
cal history, laboratory tests, as well as malaria rapid diagnostic 
tests, and was confirmed by microscopic examination of pe-
ripheral blood smears. we used the optiMAl-it rapid Malaria 
test kit (Bio-rad, france). thin blood smears were prepared as 
typical for routine hematologic staining. the slides were dried 
and fixed with methanol for 30 seconds and then stained with 
a Giemsa solution for the next 30 minutes. the dried slides 
were viewed at 1000X magnification with oil immersion. thick 
blood smears were performed using about 5 μl of blood; the 
drop was put in the center of a slide and spread to cover an 
area of approximately 10–15 mm diameter. the slide was then 
put into buffered water to allow cell lysis until the hemoglobin 
did not fall away from the smear, and then the excess water 
was removed. After that, the slides were stained with a Giemsa 
solution for 30 minutes, rinsed with tap water and dried. thick 
smears were examined under microscope as described above 
[7]. Blood parameters were measured using routine techniques. 
we analyzed data regarding time, travel destination, occupa-
tion, use of malaria prophylaxis, blood tests which were the 
most important in malaria diagnosis, such as quick rapid test for 
malaria detection, microscope blood smear assessment, white 
blood cells (wBc), red blood cells (rBc), hemoglobin, hemato-
crit, platelets, c-reactive protein (crP), alanine transaminase 
(Alt), bilirubin, creatinine.
the data was statistically analyzed. normal distribution of 
variables was checked using the shapiro–wilk test. the results 
were presented as arithmetic means and their standard devia-
tions or medians with interquartile ranges. statistical analysis 
was performed using statistica 12 software (statsoft®inc., usA).
Results
during the study period (years 2012–2016), 37 subjects 
were hospitalized. the median age was 32 years (interquartile 
range, iQr: 28–40). 25 patients were men (68%), 12 were wom-
en (32%). 15 patients (41%), including missionaries/engineers, 
worked in malaria-endemic countries. there was also 1 case of 
a laboratory technician who worked on Ebola virus detection 
in sierra leone during the period of that epidemic. 9 patients 
(24%) were travelling as tourists. 4 (11%) patients studied or 
worked in Poland, but originally came from malaria-endemic 
countries. in 9 (24%) cases, the purpose of travel was unknown.
Patients with malaria returned from Africa in 29 cases (78%), 
from Asia in 6 cases (16%), and 1 (3%) returned from central 
America. the country of travel in 1 case (3%) was unknown.
the most visited countries in Africa were kenya and uganda 
(5 patients each), cameroon and congo (4 patients each). in-
dia (2 patients) was the most visited country in Asia. 1 patient 
returned from the dominican republic in central America. 33 
patients (89%) were Polish, 1 patient was kenyan, 1 was south 
sudanese, 1 was from congo, and 1 was nigerian. Among the 33 
Poles, 1 person was a permanent resident of uganda.
we asked patients about chemoprophylaxis, and we as-
sessed the answer as “proper” when the patients took 100% 
of the pills prescribed by a physician. Proper chemoprophylaxis 
was followed in only 6 cases (16%), 5 patients (14%) followed 
chemoprophylaxis irregularly, 24 (65%) did not follow chemo-
prophylaxis at all. we were not able to determine chemopro-
phylaxis in 2 cases (5%). Among 5 patients who followed che-
moprophylaxis irregularly, 3 persons used atovaquon/proguanil, 
1 mefloquine, and 1 doxycycline. the median length of stay in 
malaria endemic countries was 1 month. the mean time to 
treatment after symptom onset was 5 days (range: 1–27 days). 
table 1 presents the statistics of laboratory variables checked 
upon admission.
Table 1. Laboratory parameters checked upon admission
Parameter n median Q25 Q75
wBc (x 103/l) 37 4.7 3.5 6.1
rBc (x 106/l) 37 4.5 4.3 4.9
hemoglobin (g/dl) 37 13.3 12.1 14.3
hematocrit (%) 37 39.0 36.0 41.0
Platelets (x103/l) 37 82 63 137
crP (mg/l) 32 68.1 30.3 124.2
Alt (u/l) 34 49 32 81
Bilirubin (µmol/l) 35 21.2 12.1 36.0
creatinine (µmol/l) 36 79 61 89
Alt – alanine transaminase, crP – c-reactive protein, rBc – red blood 
cells, Q25 – first quartile, Q75 – third quartile, wBc – white blood cells.
Median platelet count was lower than the reference range, 
and median crP, Alt and bilirubin was above the reference 
range. other variables were in the reference range. 
we also checked the percentage of patients diagnosed with 
malaria who had laboratory and radiological parameters out-
side normal ranges (table 2).
Table 2. Percentage of patients diagnosed with malaria who 
had laboratory and radiological parameters outside normal 
ranges
Parameter n %
wBc (x 103/l) 14 38
rBc (x 106/l) 5 14 
hemoglobin (g/dl) 3 8 
hematocrit (%) 14 38
Platelets (x 103/l) 26 70 
crP (mg/l) 27 84 
Alt (u/l) 25 74 
Bilirubin (µmol/l) 18 51 
creatinine(µmol/l) 1 3 
hepatomegaly 6 19
splenomegaly 20 54 
Alt – alanine transaminase, crP – c-reactive protein, rBc – red blood 
cells, wBc – white blood cells.
crP, although a non-specific parameter, was most frequent-
ly out of the reference range. Malaria specific values (low he-
matocrit, low platelet count, high Alt, bilirubin, splenomegaly) 
were present in most cases. only 2 patients in the studied group 
had all parameters within the reference range.
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and laboratory results. A patient who has come back from ma-
laria endemic regions with fever, anemia, thrombocytopenia, 
increased alanine transaminase and bilirubin levels, as well as 
splenomegaly, should not cause any diagnostic problems. 
if malaria is suspected, it is possible to do a rapid immu-
nochromatographic test to detect the Plasmodium antigen. 
there are different tests available that have high sensitivity and 
specificity, especially towards P. falciparum [10]. they provide 
quick results and may be used by untrained personnel; however, 
they do not reflect the level of parasitemia, which is crucial for 
patient prognosis and making the right therapeutic decision. 
therefore, a rapid test result must be confirmed using another 
method [11]. the gold standard for malaria diagnosis remains 
microscopic examination of a blood drop drawn from the finger-
tip, by means of a thick and thin blood smear [11]. A thick blood 
smear allows Plasmodium detection even at low parasitemia 
levels, while a thin blood smear is used for parasite species dif-
ferentiation. if malaria is suspected, a microscopic exam should 
be performed at least 3 times and must be repeated during 
treatment to monitor the response to therapy [5]. Assessment 
of the serum antibody level using indirect immunofluorescence 
is essential for retrospective confirmation of malaria. it has low 
sensitivity, however, and it does not allow one to distinguish be-
tween active and past infection or between different Plasmo-
dium species [5]. Polymerase chain reaction (Pcr) analysis plays 
a vital role in patients with mixed infection, low parasitemia or 
inconsistent results [12]. new diagnostic techniques using ge-
nome sequencing might also be applicable in parasite drug re-
sistance [13]. the usefulness of rapid tests in the diagnosis of 
malaria has been confirmed in our study. we did not observe 
any positive malaria tests and negative microscopy results from 
the same patient during our study period. All false negative 
results (i.e. a negative malaria test and a positive microscopy 
test) were found in patients with low parasitemia, which is why, 
as previously mentioned, a blood smear should also always be 
performed. it is worth emphasizing that patients with low para-
sitemia generally have a better prognosis.
Anti-malarial prophylaxis consists of protection against 
mosquito bites and chemoprophylaxis. the efficacy of chemo-
prophylaxis was described for the first time in 1901 by Giovanni 
Battista Grassi, who fought the disease in Agro Pontino, a re-
gion in central italy. we use chloroquine (in regions where 
P. falciparum resistance to antimalarial drugs does not occur), as 
well as atovaquon/proguanil, doxycycline, mefloquine and pri-
maquine (if there is resistance), as malaria chemoprophylaxis. 
chemoprophylaxis should only be recommended by physicians 
with sufficient knowledge and experience, and it ought to be 
based on information regarding the area to be visited, time of 
travel and health status of the traveler [14]. in our study group, 
only a few patients followed chemoprophylaxis properly, 65% 
of patients did not use any antimalarial drugs and some (14%) 
claimed either irregular use or use only during the initial part of 
the stay. it is worth mentioning that this proportion is most cer-
tainly underrepresented. Among the subjects who claimed to 
have followed chemoprophylaxis, irrespective of regularity, only 
one patient was a tourist, while the rest worked in endemic ar-
eas. the majority of subjects revealed that it was the employer 
who provided free antimalarial prophylaxis; hence, it is possible 
that they did not want to officially admit to exposing their com-
panies to additional costs by not using prophylaxis appropriate-
ly. it seems, however, that lack of prophylaxis in patients who 
traveled for tourist purposes was the result of their low aware-
ness of the danger of malaria. their arguments, such as price 
of medication, fear of side effects or poor access to infectious 
disease specialists, are not justified, as chemoprophylaxis costs 
are low compared to the costs of travel and potential financial 
losses resulting from the disease. Moreover, the side effects of 
the drug are hardly ever observed, and specialist consultation is 
available in large cities and sometimes even small towns.
A malaria rapid diagnostic test was performed in 32 pa-
tients. in 28 cases, the test was positive (88%), and in 4 patients, 
it was negative (12%).
All 37 cases of malaria were confirmed by microscopic ex-
amination of blood film. in 6 patients, Plasmodium was present, 
but the species of parasite was not identified, because some 
patients were already self-treated (a missionary working in the 
tropics). Among 31 patients with identified species of Plasmo-
dium, Plasmodium falciparum was the most frequent species 
(n = 23, 74%); in 7 cases (23%), P. vivax was the pathogen; in 
3 cases (10%), P. ovale was the pathogenic species. the total 
sum exceeds 100%, because 2 patients had mixed infections 
(P. falciparum–P. ovale or P. vivax–P. ovale). Median parasitemia 
at admission was 1.4 % (standard deviation, sd ± 2.9).
in the study group, the most commonly used antimalarial 
drugs were artemisinin derivatives (artesunate or artemether 
with lumefantrine, 21 patients), atovaquone/proguanil (12 pa-
tients), chloroquine (3 patients) and quinine with doxycycline 
(1 patient). following basic treatment, primaquine was used in 
patients infected with P. vivax or P. ovale. 
Discussion
Malaria is an important tropical disease imported into the 
Małopolska province in southern Poland. its presence is likely 
related to tourism; however, it is mostly associated with work in 
endemic areas, which was proven in a recent statistical analysis 
that covered all of Poland [8, 9]. P. falciparum and P. vivax are 
responsible for the majority of cases of malaria. our study has 
shown that the majority of infections were caused by P. falci-
parum or P. vivax. As many as 30 out of 31 patients (97%), in 
whom the blood smear confirmed the type of Plasmodium, 
were infected by these species. this is in line with global epide-
miological trends. the majority of cases were associated with 
travel to Africa (78%). in the Małopolska province, there are two 
large catholic dioceses (cracow and tarnow), where mission-
ary activity is of great importance. it is thus not surprising that 
many malaria patients were either clergy or laymen involved in 
missionary work or family members visiting relatives on such 
missionary work. this explains the predominance of malaria 
originating from African countries. it should also be noted that 
in recent years, the number of people working in Africa or trav-
eling to Asia has increased. the length of their stay varied due 
to the reason for traveling – up to 1 month for tourists or over 
1 year for professionals. the subjects mostly visited countries in 
the eastern part of sub-saharan Africa, such as uganda, kenya 
and tanzania. Among non-African countries, the most common 
were india and indonesia.
the mean incubation period, as of the moment of mosquito 
bite, ranges from 10 to 14 days and depends on Plasmodium 
species type. due to production of intrahepatic forms by P. vivax 
and P. ovale, malaria symptoms may appear even 1 year after the 
bite. early manifestations are non-specific and predominantly 
include malaise, headache, muscle pain, abdominal discomfort 
and fatigue. fever, nausea and vomiting appear subsequently. 
Additionally, hepatosplenomegaly and jaundice may occur. hav-
ing analyzed our data, we need to emphasize that there is an 
issue with the prompt recognition of malaria patients. the mean 
time-to-admission to our department was 5 days; however, the 
longest period was 27 days. in the analyzed group, no fatal cases 
were observed, and delayed diagnosis was reported in patients 
with a less severe form of malaria caused by P. vivax or P. ovale. 
A delay of several days in the start of P. falciparum malaria treat-
ment may lead to the patient’s death. Patients, in general, will-
ingly mention travel to tropical countries during the taking of 
a history, and even if they did not, it still should be a routine 
question asked by each physician when looking for the cause 
of fever. our results show that patients visiting emergency de-
partments or family Practices have the same typical symptoms 
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of quinine along with doxycycline administered intravenously. 
should malaria occur during pregnancy, the treatment of choice 
for uncomplicated P. falciparum infection remains quinine along 
with clindamycin in the first trimester, while a combination of 
artemisinin derivatives is used in both the second and third tri-
mester. in case of P. vivax, P. ovale, P. malariae or P. knowlesi 
infection in the first trimester of pregnancy, quinine or chlo-
roquine is used. severe malaria in pregnant women in all tri-
mesters is treated with intravenous artesunate. the treatment 
of children remains similar to that of adults; however, weight- 
-adjusted dosing is used. Moreover, primaquine must be avoid-
ed during the first 6 months of life, and doxycycline should not 
be used in patients under the age of 8 [2].
our patients were treated according to these recommenda-
tions. All of the patients survived, though 2 patients required 
treatment in the intensive care unit. the reason for this was an 
altered level of consciousness and severe dyspnoea accompa-
nied by Ards features. the symptoms resolved during treat-
ment, and no subject required intubation.
Conclusion
the clinical presentation of malaria in the studied group 
was, in most cases, typical. the observed diagnostic delay re-
sulted from not taking malaria into consideration during the 
initial differential diagnosis of fever. few travelers followed che-
moprophylaxis; hence, risk awareness in individuals travelling 
to endemic zones should be enhanced and an information kit 
about tropical diseases should be introduced to travel agencies. 
Quick diagnosis and treatment decrease the risk of death due 
to malaria. in a patient presenting with fever, malaria should al-
ways be considered in the differential diagnosis if there is a his-
tory of travel to malaria-endemic areas.
irrespective of the efficacy of chemoprophylaxis, a number 
of opinions pertaining its use has recently been published, and 
recommendations differ across countries and organizations 
[14]. while the who, centers for disease control and Preven-
tion (cdc) and the french Haut Conseil de la Santé Publique 
France guidelines recommend chemoprophylaxis for most trav-
elers heading to endemic areas [2, 15, 16], other countries (Ger-
many, switzerland, Austria) prefer the use of prophylaxis only in 
high risk regions, such as continental Africa, some parts of ocea-
nia or selected areas of the Amazon Basin [17]. the remaining 
guidelines contain a mix of the aforementioned recommen-
dations [14]. data gained by the tropnet expert panel (www.
tropnet.net) demonstrates that chemoprophylaxis is used more 
often in northern european countries than in the central part of 
the continent; furthermore, in almost every european country, 
chemoprophylaxis is used less often than the local guidelines 
recommend [18].
the current treatment of malaria according to 2016 who 
guidelines is based on the identified parasite species and the se-
verity of the disease [2]. therapy should be introduced as early 
as possible, preferably within 48 hours from symptom onset. if 
the patient followed chemoprohylaxis, a different drug should 
be chosen for the therapy. P. vivax infection acquired in an area 
where no chloroquine resistance occurs should be treated with 
this drug. in all other cases, as well as in a mild P. falciparum 
infection, combination therapy should be used. According to 
who guidelines, artemisinin derivatives (e.g.: artemether, arte-
sunate) are recommended as first-line treatment together with 
lumefantrine, mefloquine or sulfadoxine/pyrimethamine. in P. 
vivax or P. ovale infections, the basic treatment should be ad-
ditionally followed by primaquine use in order to clear the re-
maining hypnozoites, which are responsible for malaria relapse. 
in severe forms of the disease, intravenous artesunate is con-
sidered as primary therapy. the second-line treatment consists 
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